In Brief
Refine Search
Pharmaceutical
US pharma giant Merck & Co and the Bill & Melinda Gates Medical Research Institute (Gates MRI) today announced a licensing agreement for two pre-clinical antibacterial candidates for evaluation as potential components of combination regimens for the treatment of tuberculosis (TB). 18 October 2022
Biotechnology
2013-founded Belgian biotech Bioxodes has appointed Marc Dechamps as chief executive, replacing the company’s founder, Edmond Godfroid, who will become COO as well as CSO. 18 October 2022
Biotechnology
Danish microbiome company Clinical Microbiomics has acquired a local metabolomics provider, MS-Omics, for an undisclosed sum. 17 October 2022
Pharmaceutical
US biopharma company ImmuneID has appointed Jessica Atkinson as chief business officer. 17 October 2022
Pharmaceutical
A new precision medicine company, Matchpoint Therapeutics, has launched in Massachusetts, USA, with a total of $100 million in financing. 14 October 2022
Biotechnology
Belgian biopharma UCB has linked up with GliaPharm, a Swiss biotech that develops treatments for neurological and psychiatric disorders, in a strategic collaboration for the discovery of therapeutic targets in epilepsy. 14 October 2022
Pharmaceutical
The US Food and Drug Administration (FDA) has issued its guidance document Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA. 14 October 2022
Biotechnology
US biotech Odyssey Therapeutics has taken its total capital raised to $386 million. 13 October 2022
Biotechnology
UK-headquartered cancer immunotherapy company Autolus Therapeutics saw its shares leap 16% yesterday, after announcing that Moderna has exercised its option to license Autolus’ proprietary binders against an undisclosed immuno-oncology target for the development and commercialization of mRNA therapeutics. 13 October 2022
Biotechnology
Contract development and manufacturing organization (CDMO) Samsung Biologics has commenced operations at Plant 4, part of the world’s largest bio-manufacturing plant. 13 October 2022
Biotechnology
British T cell specialist Emergex Vaccines has acquired the assets of California’s Zosano Pharma, for an undisclosed amount. 12 October 2022
Biotechnology
Just days after confirming talks were in progress, UK and USA-based clinical-stage biotech PureTech today announced that it has mutually agreed with Nektar to terminate discussions regarding a possible business combination. 11 October 2022
Biotechnology
DNA sequencing firm Illumina has announced a strategic research collaboration with UK pharma major AstraZeneca. 11 October 2022
Generics
New Jersey, USA-based Amneal Pharmaceuticals today said it has launched commercial operations in India. 10 October 2022
Biotechnology
Belgian startup Ziphius Vaccines is to collaborate with University Hospital Ghent (UZ Ghent) in a public-private partnership for the scale up and manufacturing of certain self-amplifying RNA vaccines. 7 October 2022
Biotechnology
Medicines regulator Health Canada has authorized Comirnaty Original & Omicron BA.4/BA.5 as a 30μg booster dose for individuals ages 12 years and older. 7 October 2022
Biotechnology
UK and USA-based clinical-stage biotech PureTech Health’s shares fell 17% to 213.50 pence in London on Friday morning, after the company confirmed that it has “exchanged indicative, non-binding proposals” with Nektar Therapeutics regarding a possible combination, which may include, amongst other things, an offer for share capital of PureTech. 7 October 2022
Generics
The US Food and Drug Administration has published more information related to recent changes to Generic Drug User Fee Amendments (GDUFA). 7 October 2022
Pharmaceutical
British AI company BenevolentAI and pharma major AstraZeneca have moved forward their 2019-initiated drug discovery collaboration, with the latter adding two novel targets to its drug portfolio. 6 October 2022
Biotechnology
Oxford BioTherapeutics has out-licensed to Genmab a novel antibody which forms part of its program of research in immuno-oncology. 4 October 2022
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Sage Therapeutics will down tools on its dalzanemdor program, after the Phase II DIMENSION trial missed both primary and secondary endpoints. 21 November 2024
Biotechnology
San Diego-based Kura Oncology and Japan’s Kyowa Kirin have entered into a global strategic collaboration to develop and commercialize ziftomenib. 21 November 2024
Biotechnology
HCW Biologics has announced a worldwide licensing agreement with WY Biotech to develop and commercialize one of its preclinical immunotherapy candidates. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
Dutch clinical-stage biotech NewAmsterdam Pharma, which is focused on non-statin medicines for patients at risk of cardiovascular disease (CVD), has announced positive top-line data from its Phase III TANDEM clinical trial. 21 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
US clinical-stage biotech Vyriad has entered into a strategic collaboration with Swiss pharma giant Novartis to discover and develop in vivo chimeric antigen receptor (CAR) T-cell therapies. 21 November 2024
Biotechnology
The European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab), from US pharma giant Pfizer. 20 November 2024
Biotechnology
Bioplatform company builder Flagship Pioneering has announced its companies Ampersand Biomedicines and Montai Therapeutics have entered into agreements to identify targeted molecules that could potentially be further developed as treatments for obesity and lung cancer. 20 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze